APD to monitor air quality in Mangaluru during Diwali

coastaldigest.com news network
October 17, 2017

Mangaluru, Oct 17: City based NGO Anti-Pollution Drive (APD) Foundation has set up four stations across Mangaluru to monitor air quality before and during Diwali festival.

Under the ‘Shuddha Gaali’ project, the Foundation has set up air quality assessment stations at four places. The assessment of air quality started on Monday. “We will assess the air quality on Tuesday and again on Thursday and Friday (during the festival),” said Abdullah A Rehman, the founder of APD Foundation.

“Of late, many people are celebrating Diwali without firecrackers considering the ill effects crackers cause on the environment and health of the people. To motivate people to continue this trend, the foundation has planned three projects for the people. Firstly an Eco-Friendly Diwali celebration along with Karnataka State Pollution Control Board (KSPCB) that was held at Bearys Public School on Monday,” he said.

The second project is to assess the air quality to show the impact of firecrackers on environment. “This project will be supported by St George’s Homeopathy. We will be testing the air quality levels in four residential locations for two days starting Monday. Later, on Thursday and Friday, air quality will be again tested at the same locations,” he said adding that report of the air quality assessment will be submitted to the district administration, Mangaluru City Corporation and Department of forest and environment.

In addition, the APD Foundation will also conduct an advocacy drive, he said. “We will be submitting a memorandum to the district commissioner appealing him to take five problems (child labour, untoward incidents, air and noise pollution, effect on mental health and improper disposal) that are caused by fireworks into consideration and take appropriate steps.

The APD Foundation was set up in view of the fact that there is an apparent awareness, information and data deficit amongst the citizens of our country regarding environmental issues. Their key instruments towards obtaining their objective would be through holistic information, data sharing & advocacy campaign where they sensitise the people about the ill effects of pollution and drive the citizenry towards taking a more involved role in sustainable and responsible living.

Comments

A P
 - 
Thursday, 19 Oct 2017

We should encourage these kind of projects  and aim for a green Diwali, hence a cleaner environment.

 

Hope they also come up with a project to measure noise pollution 5 times a day, all 365 days in a year.

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
April 24,2020

Bengaluru, Apr 24: Karnataka is likely to start Convalescent Plasma Therapy for COVID-19 patients, who are critical, from tomorrow, Medical Education Minister K Sudhakar said here on on Friday. "We have already got approval for Convalescent Plasma Therapy.

There is no need for any special permission for it....when I was in BMC (Bangalore Medical College) I spoke to We may probably start it for the first patient from tomorrow itself. The donor has also agreed," Sudhakar said.

Speaking to reporters here, he said the convalescent Plasma Therapy was only for patients who are critical, in Intensive Care Units or on ventilator. According to the latest update, five COVID-19 patients are in ICUs in the state.

After attending video conferencing by Union Health Minister Harsh Vardhan with health and medical education Ministers of all states, Sudhakar said the Minister lauded the good practices adopted by Karnataka in its fight against COVID-19 and asked to share the same with other states.

Responding to a question, he made it clear that COVID-19 is something that was not going to end by May 3 or by May end and like other viruses, would continue to exist. Sudhakar, who is leading the government's efforts against COVID-19 in Bengaluru and is in charge of the state war room, said many people are treating corona as a social stigma, which was not right.

There was no reason to get frightened about it as the infection can be cured, he said. "We have to take precautions so that it doesn't spread further....like fever, cold and cough- corona also can be cured... 97% people it can be cured, those with comorbidity and those above 60 years have to take some precautions. We have to bring in certain changes in our lifestyle and maintain social distancing," he added.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
coastaldigest.com web desk
July 1,2020

The United States of America has bought almost the entire world's supply of remdesivir, one of just two drugs proven to treat COVID-19. 

“President Trump has struck an amazing deal to ensure Americans have access to the first authorised therapeutic for Covid-19,” said the US health and human services secretary, Alex Azar. 

“To the extent possible, we want to ensure that any American patient who needs remdesivir can get it. The Trump administration is doing everything in our power to learn more about life-saving therapeutics for Covid-19 and secure access to these options for the American people.”

The announcement implies that no other country in the world will be able to buy remdesivir for next three months at least.

The anti-viral drug patented by the US-based Gilead biotech firm is the only one approved by the European Medicines Agency (EMA) to treat patients with the novel coronavirus.

The Trump administration has already shown that it is prepared to outbid and outmanoeuvre all other countries to secure the medical supplies it needs for the US.

“They’ve got access to most of the drug supply [of remdesivir], so there’s nothing for Europe,” said Dr Andrew Hill, senior visiting research fellow at Liverpool University.

Remdesivir, the first drug approved by licensing authorities in the US to treat Covid-19, is made by Gilead and has been shown to help people recover faster from the disease. 

The first 140,000 doses, supplied to drug trials around the world, have been used up. The Trump administration has now bought more than 500,000 doses, which is all of Gilead’s production for July and 90% of August and September.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
coastaldigest.com news network
May 13,2020

Mangaluru, May 13: Kannadigas in the United Arab Emirates (UAE) have sought additional flights to return to Karnataka during a video conference with Chief Minister B S Yediyurappa here on Tuesday.

Noting that most of the ex-pats in UAE were from the coastal region, they urged the state government to ensure that most of these flights land in the Mangalore International Airport.

Many Kannadigas in the UAE were left unemployed due to the lockdown. “Many of them do not have the means to return to Karnataka and the state government should aid them,” representatives of various Kannadiga ex-pat groups urged the CM.

Yediyurappa said that the government has made all arrangements to bring back the ex-pats, and assured to fulfil all their demands.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.